Advertisement

Masters of the Air: Overcoming Airborne Pathogens Indoors

Hudson Institute 1201 Pennsylvania Avenue Northwest, #400, Washington, DC, United States

Masters of the Air: Overcoming Airborne Pathogens Indoors will be held on 7 May 2024 in Washington, DC. The focus of this meeting will be to provide the Bipartisan Commission on Biodefense with a better understanding of: How the federal government currently addresses indoor air quality New scientific and technological advances for indoor air quality

BARDA Accelerator Network Launch Event

UCI Research Park 5270 California Avenue, Irvine, CA, United States
Hybrid Hybrid Event

The BARDA Accelerator Network Launch Event will be held 15 May 2024 both virtually and in-person in Irvine, CA. The Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services unveiled the next generation of the BARDA Accelerator Network by

Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions – Fifth Meeting

National Academies of Sciences 2101 Constitution Ave NW, Washington, DC, United States
Hybrid Hybrid Event

In response to a Congressional request, an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine is conducting a study on processes for evaluating the safety and efficacy of drugs for rare diseases or conditions in the United States and the European Union. This is the fifth meeting of the committee of

Pandemic Accord: Partial Failure or Partial Success?

Virtual Event Virtual Event

The Pandemic Center will host a webinar titled Pandemic Accord: Partial Failure or Partial Success? The event will take place on 23 May 2024. A vote on the treaty is expected during the upcoming World Health Assembly, taking place 27 May through 1 June. This Pandemic Center webinar will convene an expert panel to assess

Toxic Terrors: The Menace of Toxins as Biological Weapons

Virtual Event Virtual Event

A virtual lecture on Toxic Terrors: The Menace of Toxins as Biological Weapons will be held on 24 May 2024. The event is part of a series of webinars showcasing the graduates of the Certified Biosafety Officers Expertise Training Course (CBPetc) by the BioRisk Association of the Philippines 2015, Inc. These individuals have successfully completed

2024 Blue Knight Symposium

Marriott Marquis San Diego 333 W Harbor Dr, San Diego, CA, United States

The 2024 BLUE KNIGHT Symposium will take place on 2 June 2024 in San Diego. Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA) will co-host the fourth BLUE KNIGHT Symposium in association with the 2024 BIO International Convention. Join more than 1,200 individuals, representing early-stage life science

Spring 2024 NSF Grants Conference

Philadelphia Mariott Old City One Dock St, Philadelphia, United States
Virtual Event Hybrid Event

Join the National Science Foundation (NSF) for the Spring 2024 Grants Conference from June 3 – 5, 2024, in Philadelphia, PA. The event offers virtual attendance as well. The NSF Grants Conference will provide up-to-date information about policies and procedures, specific funding opportunities, and answer attendee questions on topics including: Research.gov and SciENcv Session NSF

One Year of Implementation: USDA/APHIS Contingency Planning and Training of Personnel Rule

Virtual Event Virtual Event

After one year of implementation of the USDA APHIS Contingency Planning and Training of Personnel Rule 2022, the workshop planning committee is looking to understand the successes, challenges, and lessons learned from this rule. This workshop will focus on engaging with relevant communities to clarify the evolving definitions in the Contingency Rule, analyze the adoption

Long-Term Health Effects of COVID-19: Disability and Function Following SARS-CoV-2 Infection

Virtual Event Virtual Event

An ad hoc committee of the National Academies of Sciences, Engineering, and Medicine drafted a detailed report on the current status of diagnosis, treatment, and prognosis of long-term health effects related to Long COVID. In a public release webinar on 5 June 2024, members of the committee will provide an overview of key conclusions and